Salmeterol Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Salmeterol Salmeterol EP Impurity A VL134004View CAS 1798014-51-3
Salmeterol Salmeterol EP Impurity C VL134006View CAS 94749-11-8
Salmeterol Salmeterol EP Impurity D VL134007View CAS 1391052-04-2
Salmeterol Salmeterol EP Impurity E VL134008View CAS 108928-81-0
Salmeterol Salmeterol EP Impurity F VL134001View CAS 1391054-40-2
Salmeterol Salmeterol EP Impurity G VL134002View CAS 1391051-88-9
Salmeterol Salmeterol EP impurity B VL134005View CAS 94749-02-7
Salmeterol Salmeterol USP Realated Compound H VL134003View CAS 1330076-52-2

Salmeterol Related Compound

Salmeterol is prescribed to treat chronic obstructive pulmonary disease (COPD) symptoms such as wheezing, shortness of breath, coughing, and chest tightness.

 

References

  • https://www.facebook.com/Drugscom. “Fluticasone / Salmeterol Dosage.” Drugs.com,Drugs.com, 2022, www.drugs.com/dosage/fluticasone-salmeterol.html.
  • Ismaila, Afisi S., et al. “Impact of Adherence to Treatment with FluticasonePropionate/Salmeterol in Asthma Patients.” ResearchGate, Informa Healthcare, 26 Mar.

FAQ’s

What dose of salmeterol is available?

250/50 mcg fluticasone-salmeterol: 1 oral inhalation twice a day, about 12 hours apart

Is there a difference between salmeterol and salbutamol?

The basic difference between salmeterol and other short-acting β2 adrenoreceptor agonists (SABAs) is its duration of action.

How long does a salmeterol inhaler's duration of action last?

Salmeterol (Serevent), an inhaled beta 2-receptor agonist, has an effect duration of over twelve hours as opposed to 4-6 hours for bitolterol, fenoterol, salbutamol, and terbutaline, which have shorter half-lives.

Request a quote

108928-81-0: Salmeterol EP Impurity E

108928-81-0: Salmeterol EP Impurity E
Catalogue No.

VL134008

CAS No.

108928-81-0

Molecular Formula

C25H37NO4

Molecular Weight

415.57

Parent drug

Salmeterol

IUPAC Name

1-[4-Hydroxy-3-(hydroxymethyl)phenyl]-2-[[6-(1-methyl-3-phenylpropoxy) hexyl] amino]ethanol

Synonyms

Salmeterol Related Compound B

References

Chung, K. F. “Salmeterol/Fluticasone Combination in the Treatment of COPD.” International Journal of COPD, vol. 1, no. 3, Aug. 2006, pp. 235–42, https://doi.org/10.2147/copd.2006.1.3.235. ?

Status

In-stock

ListName

Salmeterol EP Impurity E

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url